When a pathology report arrives, the lines about ER PR and HER2 testing are often the ones people read first, because these three results shape so much of what happens next. The letters can look like a code, and it is easy to feel lost. This guide is a reading companion only, written to help you follow the words on the page, never to interpret your own result.
ER and PR are hormone receptors, tiny structures on cells that respond to the hormones estrogen and progesterone. HER2 is a different kind of marker, a protein that helps control how cells grow. Testing simply asks whether the cancer cells have each feature, and how strongly.
Knowing the general meaning of each term can steady you before an appointment and help you ask clearer questions. Your own doctor, who can see your whole report and knows your situation, is always the right person to explain what your results mean for you.
ER PR and HER2 Testing: Why These Three Tests Matter So Much
These three results help doctors describe the character of a breast cancer in a way that guides treatment. Two cancers that look alike in size can behave very differently because of these markers, and each marker can open or close the door to certain kinds of treatment.
That is why the tests are done as a routine part of diagnosis, on the tissue taken at biopsy and often checked again on tissue removed at surgery. The results sit near the top of most pathology reports, alongside the cancer type, its grade and its size.
ER and PR, Hormone Receptors in Plain Words
Receptors work a little like locks. Estrogen and progesterone are hormones that travel in the blood, and when they reach a cell that carries the matching receptor, they can act like a key and encourage that cell to grow. The ER test looks for the estrogen receptor, and the PR test looks for the progesterone receptor.
Reports may describe the result as positive or negative, and may also give a percentage showing how many of the cancer cells carry the receptor, sometimes with a note about strength. A higher share of cells with receptors generally means the cancer is more likely to respond to treatments that block hormones, which your doctor can explain in your case.
How the Laboratory Tests Receptors
The testing is done on a thin slice of the tumour tissue using special stains that colour the cells carrying each receptor. A pathologist studies the stained tissue under a microscope and records the pattern. You do not need any extra procedure for these tests, because they use tissue already taken.
HER2 and How It Is Tested
HER2 is a protein that sits on the surface of cells and helps pass growth signals inside. All breast cells have some HER2, but in some cancers the gene behind it is amplified, meaning many extra copies are made, and the cells carry far more of the protein than normal. Those cancers are described as HER2 positive.
The first HER2 test usually uses the same kind of staining as the receptor tests and gives a score. Clear scores settle the result. Scores in the middle are called equivocal, which means unclear, and they lead to a second, more precise test that counts the gene copies in the cells. That second test gives a clearer yes or no answer.
What Positive and Negative Results Mean in General
In general terms, positive means the feature was found. An ER positive or PR positive cancer carries hormone receptors, so hormone blocking treatments may form part of the plan. A HER2 positive cancer carries extra HER2, so treatments designed to target HER2 may be considered alongside other care.
Negative means the feature was not found in a meaningful amount. A cancer that is negative for all three markers is often called triple negative, and it is treated with other approaches. None of these words is a verdict on outlook by itself. They are signposts that help doctors choose tools, and only your own team can read them in your full picture.
When a Result Is Unclear and Testing Is Repeated
Sometimes a result lands in a grey area, a stain is weak, or the biopsy sample is very small. In those cases the laboratory may repeat the test, use the second counting method for HER2, or test tissue from the surgery specimen instead. Waiting for a repeated result is frustrating, but an accurate result is worth the short delay.
Results can also differ slightly between the biopsy and the surgical sample, because a tumour is not always the same in every part. If that happens, your team will explain which result they are treating as the guide and why. It is always fair to ask whether any of your results were borderline and what that means in general.
Reading Your Own Results Slowly With Your Doctor
If you read your report before your appointment, go slowly and treat it as a draft of a conversation rather than a final answer. Write down the three results, note any percentages or scores, and list the questions they raise. Words like positive can feel alarming out of context, yet in this setting they often simply describe which treatments may help.
Then bring the report to your appointment and ask your doctor to walk through it line by line. This guide can help you follow that conversation, but it cannot and should not interpret your individual result. Your team knows your full history, your other results and you, and that complete picture is what safe decisions are built on.
Frequently Asked Questions
What does ER positive mean in general?
In general, it means the cancer cells carry receptors for estrogen, so hormones can encourage them to grow, and treatments that block that effect may be useful. What it means for any one person depends on the whole report, which is a question for your own doctor.
What if my HER2 result is described as equivocal?
Equivocal means the first test could not give a clear answer, which happens fairly often with HER2. A second test that counts the gene copies is then used to settle the result. Your team will explain the final result when it arrives.
Can these results change between biopsy and surgery?
They can differ slightly, because samples come from different parts of the tumour and testing has some natural variation. If the surgical results differ, doctors usually review both sets and explain which ones will guide treatment and why.
A Note on Medical Information
The information on this website is for general educational purposes only and is not medical advice. It does not replace the advice, diagnosis, or treatment of a qualified healthcare professional. If you notice a change in your breast or have concerns about your health, please contact a healthcare professional promptly.